CTI BIOPHARMA CORP

CUSIP: 12648L601 Class: Common Stock

ORBIMED ADVISORS LLC's Holding History (CIK: 0001055951)

Note: Option positions (PUT/CALL) are excluded.

Q3 2021
Shares 7,520,600 Value ($000) $22,186 Avg Close — Range —
Q2 2021
Shares 7,520,600 Value ($000) $18,802 Avg Close — Range —
Q1 2021
Shares 7,520,600 Value ($000) $21,885 Avg Close — Range —
Q4 2020
Shares 9,520,600 Value ($000) $30,656 Avg Close — Range —
Q3 2020
Shares 9,520,600 Value ($000) $20,469 Avg Close — Range —
Q2 2020
Shares 9,520,600 Value ($000) $11,044 Avg Close — Range —
Q1 2020
Shares 9,520,600 Value ($000) $8,759 Avg Close — Range —
Q4 2019
Shares 5,000,000 Value ($000) $7,900 Avg Close — Range —
Q3 2019
Shares 5,000,000 Value ($000) $4,185 Avg Close — Range —
Q2 2019
Shares 5,000,000 Value ($000) $4,297 Avg Close — Range —
Q1 2019
Shares 5,000,000 Value ($000) $4,851 Avg Close — Range —
Q4 2018
Shares 5,000,000 Value ($000) $3,668 Avg Close — Range —
Q3 2018
Shares 5,000,000 Value ($000) $10,800 Avg Close — Range —
Q2 2018
Shares 5,000,000 Value ($000) $24,900 Avg Close — Range —
Q1 2018
Shares 5,000,000 Value ($000) $19,500 Avg Close — Range —
Q4 2017
Shares 5,000,000 Value ($000) $13,400 Avg Close — Range —
Q3 2017
Shares 5,000,000 Value ($000) $15,950 Avg Close — Range —
Q2 2017
Shares 5,000,000 Value ($000) $16,550 Avg Close — Range —